Home » Posts tagged 'indigovision'

Tag Archives: indigovision

Will Italy Do A Trump

Italy this weekend, hold the future of the Euro in its hands. Sundays referendum will show whether Italy is prepared to do a Trump and turn its back on its political establishment, whilst at the same time shaking the EU to its foundations. Massive support for Beppe Grillo the Clown Prince of Italian politics and leader of the Five Star movement could lead to the collapse of Italian Banks  and a Euro crisis  of huge proportions.  Italian voters appear to be in no mood for half measures.

They have had enough and they have smelt blood, as they continue to watch their country’s economy destroyed, blighted by the Euro and the intransigence of the Eurozones unelected bureaucrats. Sterling has been rocketing ahead over the last few weeks, much to the chagrin of the EUs bitter and disappointed leaders. Come Monday morning the political establishment not just of Italy but of the whole EU could have received the biggest shock of their political  lives, rejection by a core EU member, home of The Treaty of Rome.

Berkeley Group Holdings BKG  Produced a 33% rise in profit before tax for the half year to 31st October and is increasing its interim dividend by 11%. Earnings per share rose by 35.2% and net cash almost doubled to to £207.9m after dividends and share purchases. Because of increased stamp duty and economic uncertainty arising from the referendum reservations are down 20% on the same time last year. The Chairman disagrees  and claims that market conditions are resilient and forward sales are strong enabling the company to announce a new 5 year target of at least £3billion profit before tax in the five years from 1st May 2016. The present 3 year target of £2 billion pounds over the 3 years to April 2018 is being met. Time alone will tell whether the chairman is correct or whether the company is being impacted by uncertainty and market volatility.

James Halstead JHD is finding trading conditions are challenging and it will be difficult for it to beat the figures for the previous year. Revenue has continued to be below that of last year with the best estimate being that the shortfall could be as large as 4-5%. In particular Halstead has suffered from a shortage of plasticiser, one of its main ingredients, after an explosion at one of BASF; European plants which has led to delays, shortages and rising prices.

IndigoVision Group IND is experiencing a substantial turn round in its second half with revenues up 20% on those of the first half. In addition overheads are materially below last years and the company is now trading profitably after the first half’s losses. The full year to the end of December is now expected to end profitably.

Villas & Houses For Sale In The Greek Islands – visit;   http://www.hiddengreece.net

Daily Actions – UK Main & AIM markets 29022016

IntellisysLogoDaily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.

AIM Market

ST Rec. changed
From To
Basic Resources    
Ariana Resources Buy Neutral
Chaarat Gold Holdings Neutral Buy
Asa Resource Group Neutral Buy
Uru Metals Neutral Buy
Regency Mines Neutral Buy
Paternoster Resources Buy Neutral
Financial Services    
IPM Buy Neutral
Manx Financial Neutral Buy
Dragon-Ukrainian Properties & Development Buy Neutral
Fletcher King Neutral Buy
Impax Asset Management Group Neutral Buy
RAB Special Situations Company Buy Strong Buy
Food & Beverage    
PureCircle Buy Neutral
Health Care    
Abcam Sell Neutral
Industrial Good & Services    
APC Technology Group Neutral Buy
Nakama Group Neutral Buy
The Kellan Group Neutral Buy
Ironveld Buy Neutral
Petards Group Neutral Buy
Oil & Gas – Explorers    
Bowleven Buy Neutral
Chariot Oil & Gas Buy Neutral
Oil & Gas – Producers    
Frontera Resources Buy Neutral
Technology    
Indigovision Group Neutral Buy
Pennant International Group Neutral Buy
Simigon Neutral Buy
Telecommunications    
Alternative Networks Buy Neutral

 

 


 

Main Market

ST Rec. changed
From To
Banks    
Royal Bank of Scotland Neutral Buy
Engineering & Machinery    
Rotork Buy Neutral
Food Producers & Processors    
Associated British Foods Sell Neutral
General Retail    
Burberry Group Buy Neutral
Health    
Smith & Nephew Sell Neutral
Personal Care & Household Products    
McBride Sell Neutral
Speciality & Other Finance    
London Stock Exchange Group Neutral Sell
Support Services    
John Menzies Neutral Sell
Michael Page International Buy Neutral
Transport    
Easyjet Neutral Buy

 

RISK WARNING

Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com

 

The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.

 

DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.

The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.

Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.

Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.

No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.

Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.

Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.

Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.

Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.

 

Daily Actions – UK Main & AIM markets 22012016

IntellisysLogoDaily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.

AIM Market

ST Rec. changed
From To
Basic Resources
Condor Gold Buy Neutral
James Cropper Sell Neutral
Petropavlovsk Neutral Sell
Serabi Gold Neutral Buy
Financial Services
Amphion Innovations Neutral Buy
FastForward Innovations Neutral Buy
LondonMetric Property Buy Neutral
RAB Special Situations Company Buy Strong Buy
Starvest Buy Neutral
Food & Beverage
Real Good Food Company Buy Neutral
Health Care
AorTech International Buy Neutral
Eco Animal Health Group Sell Neutral
Industrial Good & Services
Gooch & Housego Sell Neutral
Hydro International Sell Neutral
Impellam Group Sell Neutral
James Latham Sell Neutral
Kennedy Ventures Neutral Buy
NWF Group Sell Neutral
Media
Dods Group Neutral Buy
Oil & Gas – Producers
Victoria Oil & Gas Strong Buy Buy
Technology
Access Intelligence Sell Neutral
Indigovision Group Neutral Buy
Telecommunications
Avanti Communications Group Strong Buy Buy
Travel & Leisure
Best of the Best Sell Neutral

 


 

Main Market

ST Rec. changed
From To
Beverages
SAB Miller Sell Neutral
Engineering & Machinery
Castings Sell Neutral
Vesuvius Buy Neutral
Hill & Smith Sell Neutral
Vitec Group Neutral Buy
Weir Group Buy Neutral
Food Producers & Processors
Cranswick Sell Neutral
Insurance
Jardine Lloyd Thompson Neutral Buy
Leisure & Hotels
Mitchells & Butlers Buy Neutral
JD Wetherspoon Buy Neutral
Media & Entertainment
Informa Neutral Sell
St. Ives Sell Neutral
Personal Care & Household Products
McBride Sell Neutral
Reckitt Benckiser Group Sell Neutral
Pharmaceuticals & Biotechnology
BTG Buy Neutral
Ixico Buy Neutral
Real Estate – REIS
CLS Holdings Buy Neutral
J Smart Sell Neutral
St. Modwen Properties Buy Neutral
Speciality & Other Finance
Aberdeen Asset Management Buy Neutral
Support Services
Aggreko Buy Neutral
AMEC Foster Wheeler Buy Neutral
Compass Group Sell Neutral
Berendsen Sell Neutral
Michael Page International Neutral Buy
Rexam Sell Neutral
Utilities
National Grid Sell Neutral
Severn Trent Sell Neutral
United Utilities Group Sell Neutral

 

RISK WARNING

Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com

 

The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.

 

 

DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.

Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.

Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.

No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.

Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.

Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.

Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.

Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.

 

Daily Actions – UK Main & AIM markets 19012016

IntellisysLogoDaily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.

AIM Market

ST Rec. changed
From To
Basic Resources
Amur Minerals Corporation Neutral Buy
Avocet Mining Sell Neutral
Metals Exploration Neutral Buy
Patagonia Gold Neutral Buy
Chemicals
Plant Healthcare Buy Neutral
Financial Services
FastForward Innovations Neutral Buy
Dragon-Ukrainian Properties & Development Buy Neutral
LondonMetric Property Neutral Buy
Raven Russia Buy Neutral
Health Care
AorTech International Buy Neutral
Epistem Holdings Neutral Buy
Industrial Good & Services
Ceres Power Holdings Buy Neutral
Impellam Group Sell Neutral
MobilityOne Buy Neutral
Oil & Gas – Explorers
Ascent Resources Neutral Buy
Oil & Gas – Producers
Plexus Holdings Neutral Buy
Technology
Indigovision Group Neutral Buy
Tern Neutral Buy
Toumaz Buy Neutral

 

Main Market

ST Rec. changed
From To
Banks
HSBC Neutral Buy
Heavy Construction
Henry Boot Sell Neutral
House Construction
Bovis Homes Group Neutral Buy
Electronics & Electrical Equipment
Spectris Neutral Buy
Engineering & Machinery
Castings Neutral Sell
Fenner Buy Neutral
Hill & Smith Sell Neutral
Morgan Advanced Material Neutral Buy
Food Producers & Processors
Cranswick Sell Neutral
General Retail
JD Sports Fashion Sell Neutral
Health
Bioquell Neutral Sell
Household Goods & Textiles
Headlam Group Sell Neutral
Leisure & Hotels
Mitchells & Butlers Neutral Buy
Life Assurance
Chesnara Neutral Sell
Media & Entertainment
Informa Sell Neutral
St. Ives Sell Neutral
Oil & Gas
JKX Oil & Gas Neutral Sell
Pharmaceuticals & Biotechnology
Oxford Biomedica Neutral Buy
Support Services
Michael Page International Neutral Buy
Rexam Sell Neutral
Telecommunication Services
BT Group Sell Neutral
Utilities
National Grid Sell Neutral

 

RISK WARNING

Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com

 

The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.

 

DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.

The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.

Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.

Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.

No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.

Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.

Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.

Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.

Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.

 

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.